Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

      Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

      Share Article
      share to

      New Brunswick, NJ (February 9th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer, will represent the Company in a session scheduled at 1:05 p.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 48-hrs after the live webcast.

      Media Contact
      Lindsay Hyman
      (732) 524-6297

      Investor Contact
      Lisa Romanko
      (732)524-2034

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.